Kasuwar Injector Auto A halin yanzu da Buƙatun Gaba, Nazari, Ci gaba da Hasashen Ta 2027

1650405277 FMI 12 | eTurboNews | eTN
Written by Linda Hohnholz

Anaphylactic shock shine cutar da ta fi kowa yawa a Turai da yankin Arewacin Amurka. Allergy UK ta ce, kusan kashi 20% na marasa lafiya suna fama da cutar anaphylactic a Turai. Anaphylactic shock yana buƙatar na'urorin injector auto adrenaline don a yi musu magani. Ana siyar da injunan motoci na Adrenaline a ƙarƙashin nau'o'i daban-daban, kamar Emerade, Epipen da Jext a Burtaniya. Duniya kasuwar injectors an kimanta darajar dalar Amurka miliyan 1,700, dangane da ƙima, a cikin 2016, bisa ga sabon bincike na Future Market Insights (FMI). Rahoton kan injectors na auto yana ƙara haɓaka yuwuwar haɓakar haɓaka tare da matsakaicin ƙimar girma na shekara-shekara na 15.1% zuwa 2026.

Injectors na atomatik hanya ce mai tasiri na gudanarwa don magungunan intramuscular. Halayen abokantaka na masu amfani na injectors na auto suna rage nauyin ɗaukar allura da sirinji na al'ada. Koyaya, ƙayyadaddun wayar da kan jama'a game da ingantaccen amfani da allurar mota da tsadar samfuran samfuran wasu mahimman abubuwan da ke hana ɗaukar na'urorin allurar mota cikin aikace-aikacen gaggawa. Dangane da binciken da Cibiyar Bincike ta Cibiyar Kiwon Lafiya ta Jami'ar McGill ta gudanar, marasa lafiyar da ke siyan EpiPen don gaggawa ba sa amfani da samfurin da sauri kamar yadda ya kamata.

Don ƙarin fahimtar kasuwa, nemi samfurin wannanrahoto@ https://www.futuremarketinsights.com/reports/sample/rep-gb-1642 

Bugu da ari, adadin marasa lafiya da ke ziyartar sashin gaggawa saboda tsananin cutar anaphylaxis an riga an ba su epinephrine, in ji Journal of Allergy and Clinical Immunology. Rashin yin amfani da allurar mota a daidai lokacin ya samo asali ne saboda rashin sanin alamun anaphylaxis. Irin wannan rashin sani game da cutar da samfurin yana haifar da ƙalubale masu mahimmanci, dangane da ɗaukar samfur, ga masana'antun. Baya ga mafi girman farashi, iyakataccen rayuwar alƙalamin allurar auto & ƙarƙashin wadatar kayayyaki (Ex. EpiPen) sune manyan ƙalubalen da ke hana zaɓin haƙuri ga masu allurar mota a cikin gaggawa.

Haɓaka sabbin abubuwa a cikin kayan aiki da ayyukan na'urori na masu allurar auto suna haifar da haɓaka kasuwar injector ta atomatik. A cikin Satumba 2015, Bayer HealthCare ya ba da rahoton ƙaddamar da Betaconnect- na'urar injector ta atomatik don maganin sake dawowa-remitting Multi sclerosis (RRMS). Wannan injector na auto yana ba da cikakken adadin magunguna don ingantacciyar yarda da yuwuwar rage ƙimar gabaɗaya. Ƙungiya ta SHL tana ba da nau'ikan injectors na mota iri-iri waɗanda za su iya ɗaukar canje-canje a cikin allurai, kamar babban kundin, babban danko da sauransu. Masu yin allurar auto suna mai da hankali kan inganta ayyukan masu yin allura ta atomatik don inganta kula da cututtuka da jiyya.

Don Bayani Kan Hanyar Bincike da Aka Yi Amfani da su A cikin Rahoton, Nemi TOC@ https://www.futuremarketinsights.com/toc/rep-gb-1642 
Gasa mai zafi a cikin kasuwar injectors ta auto saboda dokar kariyar haƙuri ya haifar da yanayin kasuwa na oligopolistic. Sakamakon haka, samfuran, irin su EpiPen auto-injector, BD Physioject disposable auto injector, da sauransu, sun ci gaba da kasancewa a kasuwa. Koyaya, ƙarewar haƙuri na baya-bayan nan da ƙara matsa lamba daga hukumomin gwamnati zai haifar da raguwar farashin injector na auto don haka, rage riba ga masana'antun da ke da alama. Ana sa ran injectors na motoci na yau da kullun za su gabatar da babban damar haɓaka ga masu zuba jari saboda haɓaka tallafi daga masu samar da inshora masu zaman kansu. Masu ba da sabis na inshora suna faɗuwar ɗaukar hoto akan injerar mota masu tsada sosai da kuma rufe sabbin nau'ikan nau'ikan farashin rabin farashi. Gabaɗaya kudaden shiga daga allurar da aka cika ana sa ran za su yi girma a lokacin hasashen saboda hauhawar buƙatu na isar da magunguna da aka yi niyya. Sabbin masu shiga dole ne su yi nazari sosai kan kasuwar Injector Auto don kutsawa da dorewa a cikin kasuwa mai mahimmancin farashi. Nazarin yanayin kasuwa zai ba da haske game da damar kasuwanci

FMI ta raba kasuwar injector ta duniya ta nau'in samfuri, nuni, tashar rarrabawa & yankuna. Dangane da kudaden shiga, masu allurar mota da aka riga aka cika za su riƙe babban rabon kasuwa a cikin lokacin hasashen. Akasin haka, ɓangaren masu injectors na Fillable auto-injectors zai nuna iyakataccen damar saka hannun jari, dangane da kudaden shiga, ta hanyar 2026.

Wannan rahoton na FMI ya ƙunshi wasu manyan kamfanonin da ke aiki a kasuwar injectors na motoci, kamar Sanofi, Pfizer, Inc., Becton, Dickinson da Kamfanin, Mylan NV, Novartis AG, Janssen Global Services, LLC, Antares Pharma, Amgen Inc. Bayer AG, & Eli Lilly & Company.

Tuntube Mu
Naúrar No: 1602-006
Jumeirah Bay 2
Makirci A'a: Saukewa: JLT-PH2-X2A
Jumeirah Lakes Towers
Dubai
United Arab Emirates
LinkedInTwitterblogs



Hanyoyin tushen

ABUBUWAN DA ZA KU GUDU DAGA WANNAN LABARI:

  • However, limited awareness regarding proper use of auto injectors and high price of branded products are some of the important factors curbing the adoption of auto injector devices in emergency applications.
  • The global auto injectors market was valued at US$ US$ 1,700 Mn, in terms of value, in 2016, according to the latest research by Future Market Insights (FMI).
  • Increasing innovations in materials and device functions of auto-injectors are driving the expansion of the auto injector market.

<

Game da marubucin

Linda Hohnholz

Edita a shugaba don eTurboNews bisa ga eTN HQ.

Labarai
Sanarwa na
bako
0 comments
Bayanin Cikin Lissafi
Duba duk maganganu
0
Za a son tunanin ku, don Allah sharhi.x
()
x
Share zuwa...